Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Biochemical Society Transactions|September 17, 2008
Strategies for the identification of novel inhibitors of deubiquitinating enzymesSeth J Goldenberg, Jeffrey L McDermott, Tauseef R Butt, et al.Endocrinology|March 27, 2004
Mechanisms underlying growth hormone effects in augmenting nitric oxide production and protein tyrosine nitration during endotoxin challengeTed H Elsasser, Stanislaw Kahl, Carol MacLeod, et al.Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|March 13, 2019
Integrating Prolonged Field Care Into Rough Terrain and Mountain Warfare Training: The Mountain Critical Care CourseBenjamin Nicholson, Jeremy Neskey, Ryan Stanfield, et al.Journal of Natural Products|August 31, 2004
Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatusScott S Mitchell, Benjamin Nicholson, Sy Teisan, et al.Scientific Reports|March 25, 2023
Recurrent activity in neuronal avalanchesTyler Salners, Karina E Avila, Benjamin Nicholson, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 15, 2025
Blood culture bottle shortage mitigation efforts: analysis of impact on ordering and patient impactChristopher D Doern, Melissa Whitman, Michelle Doll, et al.Assay and Drug Development Technologies|December 8, 2010
Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay formatXufan Tian, Nigora S Isamiddinova, Raymond J Peroutka, et al.Journal of Natural Products|June 1, 2005
Glaciapyrroles A, B, and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sedimentVenkat R Macherla, Jehnan Liu, Christopher Bellows, et al.Cell Biochemistry and Biophysics|May 23, 2013
Comprehensive ubiquitin E2 profiling of ten ubiquitin E3 ligasesJeffrey G Marblestone, Samir Butt, Devin M McKelvey, et al.Anti-Cancer Drugs|December 1, 2005
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agentBenjamin Nicholson, G Kenneth Lloyd, Brian R Miller, et al.Pageof 6